Carrie D'Andrea
Chief Tech/Sci/R&D Officer bei ACASTI PHARMA INC.
Vermögen: - $ am 31.03.2024
Profil
Carrie D'Andrea is currently the Vice President-Clinical Operations at Acasti Pharma, Inc. She previously held the same position at Edge Therapeutics, Inc. from 2014 to 2019 and at EryDel SpA from 2020 to 2021.
She is a graduate of Temple University (Pennsylvania).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.07.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Carrie D'Andrea
| Unternehmen | Position | Beginn |
|---|---|---|
| ACASTI PHARMA INC. | Chief Tech/Sci/R&D Officer | 08.05.2023 |
Ehemalige bekannte Positionen von Carrie D'Andrea
| Unternehmen | Position | Ende |
|---|---|---|
EryDel SpA
 EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Corporate Officer/Principal | 01.04.2021 |
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Chief Tech/Sci/R&D Officer | 01.03.2019 |
Ausbildung von Carrie D'Andrea
| Temple University (Pennsylvania) | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ACASTI PHARMA INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Health Technology |
EryDel SpA
EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Health Technology |
